Glenmark pharmaceuticals’ arm enters into co-promotion agreement with Otonomy
Glenmark pharmaceuticals’ subsidiary — Glenmark Therapeutics Inc., USA has entered into co-promotion agreement with Otonomy, Inc. a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology. Glenmark Therapeutics is dedicated to developing and commercializing a franchise of branded products for Glenmark Pharmaceuticals and is focused in the areas of respiratory and dermatology. Ryaltris … Read more



